The MYNXGRIP™ Vascular Closure Device is manufactured by Cardinal Health and is part of the Cordis portfolio.
The MYNXGRIP™ Vascular Closure Device is manufactured by Cardinal Health and is part of the Cordis portfolio.
Combining clinical safety* and ease-of-use, the Cordis EXOSEAL™ Vascular Closure Device means a more confident close and improved patient outcomes.
* Clinical data from the ‘ECLIPSE Trial’ indicates safety in terms of vascular injury, access site-related bleeding, infection or nerve injury, new ipsilateral lower extremity ischemia or SAE. Wong et al JACC Cardiovasc Interv. 2009 Aug;2(8):785-93.
Combining clinical safety* and ease-of-use, the Cordis EXOSEAL™ Vascular Closure Device means a more confident close and improved patient outcomes.